| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |